BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sexton DJ, de Freitas DG, Little MA, McHugh T, Magee C, Conlon PJ, O'Seaghdha CM. Direct-Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome. Kidney Int Rep 2018;3:784-93. [PMID: 29989039 DOI: 10.1016/j.ekir.2018.02.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int 2021;100:S1-S276. [PMID: 34556256 DOI: 10.1016/j.kint.2021.05.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
2 Bandikatla S, Maharaj S, Dadlani A, Ramsubiek K, Rojan A. Thrombosis secondary to protein-losing enteropathy (PLE): A case report and review. Thrombosis Update 2021;3:100050. [DOI: 10.1016/j.tru.2021.100050] [Reference Citation Analysis]
3 Derebail VK, Rheault MN, Kerlin BA. Role of direct oral anticoagulants in patients with kidney disease. Kidney Int 2020;97:664-75. [PMID: 32107019 DOI: 10.1016/j.kint.2019.11.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
4 Cohen O, Levy-mendelovich S, Ageno W. Rivaroxaban for the treatment of venous thromboembolism in pediatric patients. Expert Review of Cardiovascular Therapy 2020;18:733-41. [DOI: 10.1080/14779072.2020.1823218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Obata F, Abe H, Murakami T, Ueda S, Inagaki T, Minato M, Ono H, Nishimura K, Shibata E, Tamaki M, Kishi F, Kishi S, Nagai K, Doi T. Direct oral anticoagulant successfully used to treat an adult nephrotic patient complicated with portal vein thrombosis. CEN Case Rep 2019;8:134-8. [PMID: 30721455 DOI: 10.1007/s13730-019-00381-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
6 Lin R, McDonald G, Jolly T, Batten A, Chacko B. A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome. Kidney Int Rep 2020;5:435-47. [PMID: 32274450 DOI: 10.1016/j.ekir.2019.12.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
7 Boyer O, Schaefer F, Haffner D, Bockenhauer D, Hölttä T, Bérody S, Webb H, Heselden M, Lipska-Zie Tkiewicz BS, Ozaltin F, Levtchenko E, Vivarelli M. Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group. Nat Rev Nephrol 2021;17:277-89. [PMID: 33514942 DOI: 10.1038/s41581-020-00384-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Matta A, Elenizi K, AlHarthi R, Moussallem N, Elhajjaji N, Lhermusier T, Carrié D. A Case of Isolated Unilateral Right Renal Vein Thrombosis Associated with Bilateral Pulmonary Embolism Treated with Rivaroxaban a Direct-Acting Oral Anticoagulant. Am J Case Rep 2019;20:1152-4. [PMID: 31383838 DOI: 10.12659/AJCR.916638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Reynolds ML, Nachman PH, Mooberry MJ, Crona DJ, Derebail VK. Recurrent venous thromboembolism in primary membranous nephropathy despite direct Xa inhibitor therapy. J Nephrol 2019;32:669-72. [PMID: 30421320 DOI: 10.1007/s40620-018-0552-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
10 Neoh KK, Tang ASN, Looi I, Anita BM. Ischemic Stroke in a Young Patient with Nephrotic Syndrome and Antiphospholipid Syndrome. Case Rep Nephrol 2020;2020:8828864. [PMID: 33294240 DOI: 10.1155/2020/8828864] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Zou H, Li Y, Xu G. Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy. BMC Nephrol 2019;20:442. [PMID: 31791286 DOI: 10.1186/s12882-019-1637-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]